A highly relevant functional interaction between REDD1 and mutant RAS is further supported by our observation that REDD1 expression is associated with clinical outcomes selectively in human RAS mutant, but not RAS wild-type lung and pancreas tumors. This evidence concerns the gene DDIT4 and digestive system neoplasm.